Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme
Status:
Withdrawn
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus carboplatin in
treating patients who have recurrent glioblastoma multiforme.